The aspartate aminotransaminase/alanine aminotransaminase (De Ritis) ratio predicts sensitivity to radiotherapy in head and neck carcinoma patients.

Aina SansaMaría Del Prado VenegasCristina ValeroLaura PardoFrancesc Xavier Avilés-JuradoXimena TerraMiquel QuerXavier Leon Vintro

Published in: Head & neck (2021)

The AST/ALT ratio was independently associated with the risk of local recurrence in patients with HNSCC treated with radiotherapy or chemoradiotherapy.

Keyphrases

locally advanced
early stage
end stage renal disease
newly diagnosed
radiation therapy
chronic kidney disease
ejection fraction
rectal cancer
squamous cell carcinoma
patient reported outcomes
patient reported